Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/17/2014 04/21/2014 04/22/2014 04/23/2014 04/24/2014 Date
64.17(c) 65.47(c) 68.3(c) 66.92(c) 66.25 Last
1 387 435 1 103 834 1 862 312 1 451 854 979 108 Volume
-0.34% +2.03% +4.32% -2.02% -1.00% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs. The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Biotechnology
Calendar
05/01Earnings Release
Surperformance© rating of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 594 M
EBIT 2014 -536 M
Net income 2014 -550 M
Finance 2014 75,6 M
Yield 2014 -
Sales 2015 1 485 M
EBIT 2015 258 M
Net income 2015 280 M
Finance 2015 226 M
Yield 2015 -
PER 2014 -
PER 2015 92,74
EV / Sales 2014 27,0x
EV / Sales 2015 10,7x
Capitalization 16 126 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
8h ago VERTEX PHARMACEUTICALS : Assigned Patent
2d ago Gilead profit triples, hepatitis C drug sales beat by $1 billion
04/17 Analysis - Fidelity biotech fund among worst performers in April sell-off
04/16 VERTEX PHARMACEUTICALS : Patent Issued for Inhibitors of Serine Proteases, Parti..
04/16 VERTEX PHARMACEUTICALS : to Announce First Quarter 2014 Financial Results on May..
04/16 VERTEX PHARMACEUTICALS : Studies from Vertex Pharmaceuticals Further Understandi..
04/16 VERTEX PHARMACEUTICALS : "Formulations of ®-1-(2,2-Difluorobenzo Dioxol-5-Yl)-N-..
04/10 VERTEX PHARMACEUTICALS : to Announce First Quarter 2014 Financial Results on May..
04/10 VERTEX PHARMACEUTICALS : Patent Issued for Processes for the Facile Synthesis of..
04/10 VERTEX PHARMACEUTICALS : Patent Issued for Compounds Useful as Inhibitors of Jan..
04/04 Momentum names may see more pain
04/02 VERTEX PHARMACEUTICALS : Patent Issued for Automated Developer for Immuno-Staine..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
Vertex Pharmaceuticals Inc : Income Statement Evolution
More Financials
EPS Revisions
Vertex Pharmaceuticals Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF